Adarx Pharmaceuticals, Inc.

This study is testing whether a new medication called ADX-038, given as an injection under the skin, can slow the progression of geographic atrophy—a form of age-related macular degeneration that causes permanent vision loss. About 240 participants with this condition will receiv…

This study is testing an experimental drug called ADX-038 for adults with specific immune-related kidney diseases. Researchers want to see if the drug is safe and effective at controlling these conditions. The trial will enroll 45 participants who have been diagnosed with disease…

This study is testing a new drug called ADX-324 to see if it can prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). It will involve about 90 adults with HAE who will receive either the drug or a placebo. The main goal is to see if the drug reduces…

This is the first study to test ADX-626 in people. Researchers will give the drug to 44 healthy adults to check if it's safe and how the body processes it. They'll also measure how it affects certain blood clotting factors.